Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
By Chih-Cheng Lai, Tzu-Ping Shih, Wen-Chien Ko, Hung-Jen Tang, Po-Ren Hsueh. International Journal of Antimicrobial Agents, 2020
5,399 citations recorded by the source corpus.
ABSTRACT The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with >99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24–3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond.
Subfields: Infectious Diseases, Modeling and Simulation
View Paper: https://www.semanticscholar.org/paper/d42b22e21c2e59125ed4fb3a2d24a857754eb7c2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Dinh C. Nguyen
- Quoc-Viet Pham
- Pubudu N. Pathirana
- Thien Huynh-The
- Won-Joo Hwang
- Ming Ding
- Binh-Son Hua
- Iván Franch-Pardo
Citations in the corpus
- Assessing the anxiety level of Iranian general population during COVID-19 outbreak (2020, neutral): “It is spread by human-to-human transmission via droplets or direct contact, and infection has been predicted to have mean incubation period of 6.4 days and a basic reproduction number of 2.24–3.58 (Lai et al., 2020).”
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study (2020, neutral): “In late December 2019, an outbreak of an emerging disease (COVID-19) due to a novel coronavirus (named SARS-CoV-2 latter) began in Wuhan, China and quickly spread in a substantial number of countries [1,2].”
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update (2020, neutral): “Additionally, the advancement and convenience of global travel could further facilitate the worldwide spread of SARS-CoV-2 [34,37].”
- Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis (2020, neutral): “Human coronaviruses are among the pathogens causing viral respiratory infections, and the recently detected strain called SARS-CoV-2 has caused a big challenge for countries all over the world (15, 16) .”
- The geography of COVID‐19 and the structure of local economies: The case of Italy (2020, neutral): “Other studies also provide similar estimates (e.g. Backer et al., 2020; Lai et al., 2020).”
- A preliminary assessment of the impact of COVID-19 on environment – A case study of China (2020, neutral): “The global outbreak and spread of COVID-19 not only seriously threatens public health (Bai et al., 2020; Sohrabi et al., 2020) , but also greatly hinders global economic growth (Lai et al., 2020) .”
- CovXNet: A multi-dilation convolutional neural network for automatic COVID-19 and other pneumonia detection from chest X-ray images with transferable multi-receptive feature optimization (2020, neutral): “Coronavirus disease (COVID-19), caused by SARS-CoV-2, has been declared as a global pandemic by WHO that almost collapsed the healthcare systems in many of the countries [1,2].”
- Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths (2020, neutral): “Increased dissemination of information through use of the internet is associated with increased transmission of information from all geographical regions and across disciplines regarding recognition of SARS-CoV-2 and COVID-19 6 ; nevertheless, important factors associated with COVID-19, specifically”
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (2020, neutral): “In late December 2019, an outbreak of an emerging disease COVID-19) due to a novel coronavirus (later named SARS-CoV) started in Wuhan, China and rapidly spread in China and outide [1 , 2] .”